Related Experiment Video
Updated: Aug 5, 2026
09:49
Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
Published on: July 5, 2019
Rare Fusions, Real Targets: Ultraprecision Oncology in Lung Cancer
1Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer Discovery
|August 3, 2026
Summary
Emerging ultrarare gene fusions, like EGFR-SHC1, reveal new cancer activation mechanisms. These rare genomic events are advancing precision oncology towards ultra-personalized cancer treatments.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Established rare gene fusions (e.g., ALK, ROS1) are key in cancer therapy.
- Emerging ultrarare fusions represent a growing area of research.
Purpose of the Study:
- To investigate novel oncogenic activation mechanisms driven by ultrarare fusions.
- To identify new therapeutic strategies based on these genomic events.
Main Methods:
- Genomic analysis of tumor samples.
- Identification and characterization of gene fusions.
- Functional studies to determine oncogenic potential.
Main Results:
- Discovery of ultrarare fusions, such as EGFR-SHC1.
- Elucidation of novel pathways for oncogenic activation.
- Potential therapeutic targets identified.
Conclusions:
- Ultrarare genomic events are crucial for understanding cancer.
- These findings support the advancement of ultraprecision cancer therapy.
- Personalized treatment strategies are becoming increasingly individualized.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...